2 recruiting, 2 unknown, 1 completed, 1 not yet recruiting. 3 Phase 2, 2 Not applicable, 1 Early Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Unknown 1, Withdrawn 1 |
| Not applicable | 2 | Recruiting 1, Unknown 1 |
| Early Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Recruiting 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow FMT: new trials by email Literature Review of FMT trials Research Report on FMT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fecal Microbiota Transplantation for Type 2 Diabetes Mellitus and Hashimoto's Thyroiditis Fecal microbiota transplantation oral capsules - Autoimmune Thyroid Disease, Type 2 Diabetes Mellitus (T2DM) | Phase 4 | Not yet recruiting | Shen Xujun | 38 | 2026-08-01 | 2026-07-29 |
| FMT Capsules for rCDI Healthy donor stool, placebo capsule - Clostridioides Difficile Infection Recurrence, FMT | Phase 3 | Recruiting | Helsinki University Central Hospital | 76 | 2026-04-25 | 2026-04-29 |
| Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis Lyophilized fecal microbiota transplantation capsules, Placebo capsules, A. soehngenii - Non Alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease | Phase 2 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 48 | 2023-03-17 | 2024-08-27 |
| Assessing the Potential Role of the Gut Microbiome in Modulating Physical Abilities in Humans Antibiotics, Autologous Fecal Microbiota Transplantation, Cellules Pills - Physical Abilities, FMT | Not applicable | Recruiting | Assaf-Harofeh Medical Center | 70 | 2022-06-29 | 2026-10-13 |
| The Role of Microbiome in Recurrent Obesity Fecal microbiota transplantation (FMT), Placebo - Obesity, Weight Loss | Not applicable | Unknown | Assaf Harofeh MC | 300 | 2022-01-01 | 2021-12-28 |
| Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC) Metronidazole, Placebo, Vancomycin - Ulcerative Colitis, FMT | Early Phase 1 | Terminated | Ari M Grinspan | 4 | 2021-11-10 | 2024-02-26 |
| Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT) CP101, Placebo - Autism Spectrum Disorder, Autism | Phase 2 | Withdrawn | Finch Research and Development LLC. | 2020-05-01 | 2021-04-08 | |
| Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection CP101 - Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection | Phase 2 | Completed | Finch Research and Development LLC. | 132 | 2018-05-01 | 2022-08-30 |
Clostridium Infections (2) · Autism Spectrum Disorder (1) · Autistic Disorder (1) · Child Development Disorders, Pervasive (1) · Colitis, Ulcerative (1) · Diabetes Insipidus, Neurogenic (1) · Diabetes Mellitus, Type 2 (1) · Non-alcoholic Fatty Liver Disease (1) · Obesity (1) · Weight Loss (1)
Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Digestive System Diseases (2) · Endocrine System Diseases (2) · Gram-Positive Bacterial Infections (2) · Infections (2) · Nutritional and Metabolic Diseases (2) · Body Weight (1) · Body Weight Changes (1) · Colitis (1) · Colonic Diseases (1) · Diabetes Insipidus (1) · Diabetes Mellitus (1) · Fatty Liver (1) · Female Urogenital Diseases (1)
Fecal Microbiota Transplantation (4) · Metronidazole (2) · Anti-Bacterial Agents (1) · Ciprofloxacin (1) · Vancomycin (1) · fructooligosaccharide (1)
Finch Research and Development LLC. (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Ari M Grinspan (1) · Assaf Harofeh MC (1) · Assaf-Harofeh Medical Center (1) · Helsinki University Central Hospital (1) · Shen Xujun (1)
United States (2) · Canada (1) · Finland (1) · Israel (1) · Netherlands (1)
Ilan Youngster, Dr. (2) · A.G. Holleboom, MD, PhD (1) · Ari Grinspan, MD (1) · Perttu Arkkila, Professor (1) · Zain Kassam, MD, MPH (1)